Diagnostics

New Technology for Evaluating Drug Susceptibility Needed

Published in AIDS Weekly, September 11th, 1995

The development of new technologies to rapidly diagnose tuberculosis and identify patterns of drug susceptibility in immunocompromised HIV infected persons is critical, according to the director of the U.S. Centers for Disease Control and Prevention's (CDC) Division of Tuberculosis Elimination.

Writing in a supplemental issue of Clinical Infectious Diseases, Ken Castro noted that new technologies for identifying latent tuberculosis among HIV positive and other immunocompromised persons are also needed.

"Because of the emergence of multidrug-resistant TB and its adverse effect on persons infected with HIV, new drugs and modalities for treating and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1995-09-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry